Pharma & Biotech AstraZeneca's Wainua failure hurts credibility more than valuation, Jefferies warns By Ian Lyall 09/07
Pharma & Biotech AstraZeneca's £19bn blow as Wainua heart drug fails key late-stage trial By Ian Lyall 09/07
Pharma & Biotech Novo Nordisk shares dip as latest prescription data points to GLP-1 pill slowdown By Ian Lyall 08/07
Pharma & Biotech Coiled Therapeutics develops improved formulation of experimental cancer drug ahead of trial expansion By Ian Lyall 07/07
Pharma & Biotech IXICO lifts revenue forecast on contract wins and wider client base - UPDATE By Ian Lyall 07/07
Pharma & Biotech SMALL-CAP MOVERS: AIM gets the summer fundraising bug as investors back helium, batteries and weight-loss pills By Ian Lyall 03/07
Pharma & Biotech EMV Capital to deconsolidate Glycotest and ProAxsis after fundraisings By Ian Lyall 01/07
Pharma & Biotech Abivax shares jump as updated trial data eases safety concerns By Emily Jarvie 30/06
Pharma & Biotech Poolbeg Pharma secures South African patent for lead drug candidate - UPDATE By Ian Lyall 30/06
Pharma & Biotech Futura Medical reports 'highly positive' data for female sexual health treatment By Ian Lyall 30/06
Pharma & Biotech Citi says Wegovy pill outpacing rivals as oral GLP-1 race heats up By Ian Lyall 29/06
Pharma & Biotech genedrive shares climb 8% on Thermo Fisher pharmacogenetic testing deal By Ian Lyall 29/06
Pharma & Biotech Futura swaps Haleon for Market Performance Group to drive US Eroxon sales - UPDATE By Ian Lyall 29/06
Pharma & Biotech Scancell confirms advanced talks over reverse merger with Neuphoria By Ian Lyall 26/06
Pharma & Biotech Jefferies names AstraZeneca a top pick ahead of pivotal heart drug readout By Ian Lyall 26/06
Medical technology & services Advanced Medical Solutions shares jump 16% on £659 million takeover by US adhesives group H.B. Fuller By Ian Lyall 25/06
